Report ID: SQMIG35A2207
Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type(implantable cardioverter defibrillators, external cardioverter defibrillators), By End use(hospitals, pre-hospital, public access market, alternative care), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2207 |
Region:
Global |
Published Date: February, 2024
Pages:
224
|
Tables:
64 |
Figures:
75
Cardioverter Defibrillator Device Market Regional Insights
North America is expected to hold the largest market share during the forecast period due to initiatives taken by key players, favorable regulations, and advanced technological facilities in the U.S and Canada.
In 2020, Bostan Scientific distributed about 33,000 CRT-Ds line up that include Resonate, Autogen, Dynagen, Incepta, and Cognis devices worldwide. Out of these, 16,500 were registered in the U.S alone indicating high adoption rate.
Asia Pacific region is projected to expand at the fastest CAGR during the forecast period. The market growth is attributed to the developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases. regional growth is fast due to the Japanese market having high penetration of defibrillators and supportive policies
Cardioverter Defibrillator Device Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
